Insider Trading & Ownership - Vivo Opportunity Fund L.P.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Vivo Opportunity Fund L.P.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-01-31
Purchase
2022-01-31
9:30 pm
Sierra Oncology Inc. SRRA Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
Vivo Capital IX LLC
Vivo Capital Fund IX L.P.
VIVO VENTURES VII LLC
Vivo Ventures Fund VII L.P.
Vivo Ventures VII Affiliates Fund L.P.
10% Owner
800,000 $27 $21,600,000 3,329,512
(Indirect)
View
2021-02-09
Purchase
2021-02-09
3:37 pm
Bolt Biotherapeutics Inc. BOLT Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Panda Fund L.P.
Vivo Panda LLC
Vivo Opportunity Fund L.P.
Vivo Opportunity LLC
10% Owner
350,000 $20 $7,000,000 150,000
(Indirect)
View
2021-02-09
Sale
2021-02-09
3:37 pm
Bolt Biotherapeutics Inc. BOLT Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Panda Fund L.P.
Vivo Panda LLC
Vivo Opportunity Fund L.P.
Vivo Opportunity LLC
10% Owner
226 $20 $4,520 150,000
(Indirect)
View
2021-02-09
Purchase
2021-02-09
3:08 pm
Terns Pharmaceuticals Inc. TERN Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
475,000 $17 $8,075,000 357,353
(Indirect)
View
2020-07-21
Purchase
2020-07-21
8:25 pm
ALX ONCOLOGY HOLDINGS INC ALXO Vivo Capital IX LLC
Vivo Capital Fund IX L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
975,000 $19 $18,525,000 185,526
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-01-26
Exercise
2022-01-28
8:12 pm
2020-01-22
N/A
Sierra Oncology Inc. SRRA Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
Vivo Capital IX LLC
Vivo Capital Fund IX L.P.
VIVO VENTURES VII LLC
Vivo Ventures Fund VII L.P.
Vivo Ventures VII Affiliates Fund L.P.
10% Owner
2,468,310 $13.2 431,947
(Indirect)
View
2021-02-09
Exercise
2021-02-09
3:37 pm
N/A
2028-07-26
Bolt Biotherapeutics Inc. BOLT Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Panda Fund L.P.
Vivo Panda LLC
Vivo Opportunity Fund L.P.
Vivo Opportunity LLC
10% Owner
64,319 $0 150,000
(Indirect)
View
2021-02-09
Conversion
2021-02-09
3:37 pm
N/A
N/A
Bolt Biotherapeutics Inc. BOLT Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Panda Fund L.P.
Vivo Panda LLC
Vivo Opportunity Fund L.P.
Vivo Opportunity LLC
10% Owner
3,414,343 $0 150,000
(Indirect)
View
2021-02-09
Exercise
2021-02-09
3:37 pm
N/A
N/A
Bolt Biotherapeutics Inc. BOLT Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Panda Fund L.P.
Vivo Panda LLC
Vivo Opportunity Fund L.P.
Vivo Opportunity LLC
10% Owner
64,319 $0.07 150,000
(Indirect)
View
2021-02-09
Conversion
2021-02-09
3:08 pm
N/A
N/A
Terns Pharmaceuticals Inc. TERN Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
3,426,240 $0 357,353
(Indirect)
View
2020-07-21
Conversion
2020-07-21
8:25 pm
N/A
N/A
ALX ONCOLOGY HOLDINGS INC ALXO Vivo Capital IX LLC
Vivo Capital Fund IX L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
6,403,899 $0 185,526
(Indirect)
View